Medicare Enrolled

Dr. Rhonda Murphy, PA-C

Medical Physician Assistant · Wyomissing, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2760 CENTURY BLVD, Wyomissing, PA 19610
6103754251
In practice since 2008 (18 years)
NPI: 1376707422 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Murphy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Murphy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Murphy

Dr. Rhonda Murphy is a medical physician assistant in Wyomissing, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Murphy performed 14,064 Medicare services across 1,128 unique beneficiaries.

Between the years covered by Open Payments, Dr. Murphy received a total of $9,157 from 30 pharmaceutical and/or device companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Murphy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in PA $9,157 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,064
Medicare services
Top 0% in PA for medical physician assistant
1,128
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~781 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
5,620 $26 $174
Denosumab injection (Prolia/Xgeva) 4,560 $18 $34
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
1,296 $13 $35
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
379 $8 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
374 $76 $250
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
292 $8 $25
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
282 $1 $11
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
251 $4 $25
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
249 $1 $26
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
198 $85 $500
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
130 $19 $300
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
100 $48 $342
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
88 $9 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
71 $109 $300
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
55 $42 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $52 $200
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
39 $32 $120
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
15 $18 $62
X-ray of lower and sacral spine, minimum of 4 views
An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints.
11 $31 $124
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
43.5% high complexity
45.9% medium
10.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,157
Total received (2021-2024)
Avg $2,289/year across 4 years
Top 3% in PA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
385
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,157 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,273
2023
$4,145
2022
$2,477
2021
$262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$459
UCB, Inc.
$307
Janssen Biotech, Inc.
$290
Amgen Inc.
$228
GlaxoSmithKline, LLC.
$217
Lilly USA, LLC
$151
GENZYME CORPORATION
$75
Genentech USA, Inc.
$57
E.R. Squibb & Sons, L.L.C.
$55
AstraZeneca Pharmaceuticals LP
$52
PFIZER INC.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Radius Health, Inc.
$45
Fresenius Kabi USA, LLC
$42
Organon Llc
$33
Sandoz Inc.
$31
Novartis Pharmaceuticals Corporation
$31
Actelion Pharmaceuticals US, Inc.
$22
Kyowa Kirin, Inc.
$22
SOBI, INC
$20
Aurinia Pharma U.S., Inc.
$19
Mallinckrodt Hospital Products Inc.
$18
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,775
Amgen Inc.
$1,340
Janssen Biotech, Inc.
$1,059
UCB, Inc.
$788
Lilly USA, LLC
$638
GlaxoSmithKline, LLC.
$507
Horizon Therapeutics plc
$397
Mallinckrodt Hospital Products Inc.
$320
E.R. Squibb & Sons, L.L.C.
$260
AstraZeneca Pharmaceuticals LP
$231
PFIZER INC.
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
Aurinia Pharma U.S., Inc.
$163
Novartis Pharmaceuticals Corporation
$162
AbbVie Inc.
$153
Genentech USA, Inc.
$151
Fresenius Kabi USA, LLC
$128
Organon LLC
$124
GENZYME CORPORATION
$95
SOBI, INC
$77
Alexion Pharmaceuticals, Inc.
$64
Radius Health, Inc.
$62
Actelion Pharmaceuticals US, Inc.
$57
Organon Llc
$33
ANI Pharmaceuticals, Inc.
$32
Sandoz Inc.
$31
Fidia Pharma USA Inc.
$25
Kyowa Kirin, Inc.
$22
DePuy Synthes Sales Inc.
$22
Sobi, Inc
$18
Top 3 companies account for 45.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · IDACIO · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · UPTRAVI · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for medical physician assistant in PA.

Looking for a medical physician assistant in Wyomissing?
Compare medical physician assistants in the Wyomissing area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
167
Per 100K population
38.8
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Murphy is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 3% of PA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Murphy experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Murphy performed 5,620 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Murphy receive payments from pharmaceutical companies?
Yes. Dr. Murphy received a total of $9,157 from 30 companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Murphy's costs compare to other medical physician assistants in Wyomissing?
Dr. Murphy's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Murphy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →